This month, two of the hottest AI companies in San Francisco announced a major push into healthcare — moves that experts say were not only inevitable, but also timely and high-stakes. Anthropic and ...
About 31,000 Kaiser Permanente healthcare workers plan to launch an open-ended strike over staffing shortages, wages and care access issues — potentially affecting dozens of hospitals and hundreds of ...
It’s not often that a pharmaceutical executive discusses a competitor’s success. Alkermes Chief Operating Officer Blair Jackson not only talks about it openly, he cheers it. Alkermes’s scope in ...
During two House hearings, health insurance CEOs were questioned on rising healthcare costs, vertical integration and prior authorization.
This week, Congress reached a bipartisan healthcare deal as part of a larger $1.2 trillion spending bill, combining funding ...
Bristol Myers Squibb hasn’t had much luck with its efforts to develop cancer treatments called T cell engagers. But the pharmaceutical company isn’t done pursuing this type of targeted cancer therapy, ...
Pfizer is getting out of the business of developing and marketing HIV medicines by exiting its minority stake in ViiV Healthcare, a company the pharmaceutical giant formed in partnership with GSK 17 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results